Discontinued — last reported Q1 '18
Allowance for Doubtful Accounts Receivable (Current)
Thermo Fisher Scientific Allowance for Doubtful Accounts Receivable (Current) decreased by 3.1% to $155.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 24.0%, from $204.00M to $155.00M. Over 4 years (FY 2020 to FY 2024), Allowance for Doubtful Accounts Receivable (Current) shows an upward trend with a 6.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
Detailed definition
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Peer comparison
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_currentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $135.00M | $138.00M | $150.00M | $170.00M | $177.00M | $185.00M | $189.00M | $190.00M | $180.00M | $184.00M | $193.00M | $197.00M | $202.00M | $204.00M | $173.00M | $165.00M | $160.00M | $155.00M |
| QoQ Change | — | +2.2% | +8.7% | +13.3% | +4.1% | +4.5% | +2.2% | +0.5% | -5.3% | +2.2% | +4.9% | +2.1% | +2.5% | +1.0% | -15.2% | -4.6% | -3.0% | -3.1% |
| YoY Change | — | — | — | — | +31.1% | +34.1% | +26.0% | +11.8% | +1.7% | -0.5% | +2.1% | +3.7% | +12.2% | +10.9% | -10.4% | -16.2% | -20.8% | -24.0% |
Allowance for Doubtful Accounts Receivable (Current) at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's allowance for doubtful accounts receivable (current)?
- Thermo Fisher Scientific (TMO) reported allowance for doubtful accounts receivable (current) of $155.00M in Q3 2025.
- How has Thermo Fisher Scientific's allowance for doubtful accounts receivable (current) changed year-over-year?
- Thermo Fisher Scientific's allowance for doubtful accounts receivable (current) decreased by 24.0% year-over-year, from $204.00M to $155.00M.
- What is the long-term trend for Thermo Fisher Scientific's allowance for doubtful accounts receivable (current)?
- Over 4 years (2020 to 2024), Thermo Fisher Scientific's allowance for doubtful accounts receivable (current) has grown at a 6.4% compound annual growth rate (CAGR), from $135.00M to $173.00M.
- What does allowance for doubtful accounts receivable (current) mean?
- The estimated portion of customer invoices that the company expects will never be paid.